SUSPENDED

Decision Making in Chronic Pain and Alcohol Use Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this within-subject study is to test the effects of Episodic Future Thinking (EFT) and Low-intensity Focused Ultrasound (LIFU) interventions on the pain of subjects who have chronic pain and alcohol use disorder(s).

Official Title

Decision Making in Chronic Pain and Alcohol Use Disorder

Quick Facts

Study Start:2024-06-28
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:SUSPENDED

Study ID

NCT05901610

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 21 years old or older
  2. 2. Report chronic pain
  3. 3. Have sufficiently stable self-reported mental and physical health in order to complete the survey
  4. 4. Meet DSM-V clinical criteria for alcohol use disorder (i.e., four or more criteria)
  5. 5. Not have unmanaged medical or psychiatric conditions the survey
  1. 1. Claustrophobia (scanning environment may be uncomfortable)
  2. 2. Contraindications to MRI: including pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants.
  3. 3. Contraindications to CT: pregnancy
  4. 4. Active medical disorder or treatment with potential CNS effects (e.g. Alzheimer's)
  5. 5. History of neurologic disorder (e.g. Parkinson's, Epilepsy, or Essential Tremor)
  6. 6. History of head injury resulting in loss of consciousness for \>10 minutes
  7. 7. Failure to provide a Social Security Number or Tax ID number. This is required for tax purposes.

Contacts and Locations

Principal Investigator

Wynn Legon, PhD
PRINCIPAL_INVESTIGATOR
Virginia Polytechnic and State University

Study Locations (Sites)

Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, 24016
United States

Collaborators and Investigators

Sponsor: Virginia Polytechnic Institute and State University

  • Wynn Legon, PhD, PRINCIPAL_INVESTIGATOR, Virginia Polytechnic and State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-28
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2024-06-28
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Alcohol Use Disorder
  • Chronic Pain